Cargando…
MEDB-57.GNAS inactivation as a driver for sonic hedgehog-activated medulloblastoma
INTRODUCTION: Sonic hedgehog (SHH)-activated medulloblastoma is one of the four consensus molecular subgroups of medulloblastoma and is typically associated with PTCH1, SUFU, and/or SMO mutations. GNAS inactivating mutations are a less commonly recognized tumorigenic driver for SHH pathway activatio...
Autores principales: | Goode, Erin, Montoya, Liliana, Graham, Eric, Pruniski, Brianna, Simmons, Curtis, Ngwube, Alexander, Hoffman, Lindsey M, Tiwari, Nishant, Aldape, Kenneth, Price, Harper N, Paulson, Vera, Mangum, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165066/ http://dx.doi.org/10.1093/neuonc/noac079.431 |
Ejemplares similares
-
MEDB-52. Organoids as preclinical models to improve and personalize disease outcome for sonic hedgehog medulloblastoma
por: Odé, Zelda, et al.
Publicado: (2022) -
MEDB-02. The identification and functional characterization of circular RNA Circ_63706 in sonic hedgehog medulloblastomas
por: Pokhrel, Rudramani, et al.
Publicado: (2022) -
MEDB-45. Functional genomics identifies epigenetic regulators as novel therapeutic targets for sonic hedgehog medulloblastoma
por: Tsiami, Foteini, et al.
Publicado: (2022) -
MEDB-06. Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that loss of heterogeneity and induced differentiation underlies the response to CDK4/6 inhibition
por: Vo, Tuan, et al.
Publicado: (2022) -
MEDB-41. Identifying a subgroup of patients with early childhood sonic hedgehog-activated medulloblastoma with unfavorable prognosis after treatment with radiation-sparing regimens including intraventricular methotrexate
por: Tonn, Svenja, et al.
Publicado: (2022)